Name	Value
Compound	Ly5
Investigated event	Influence on protein activity ex vivo
Experiment type	Western Blot
Concentration	10.00 µM
Cell line	MG63.3
Organism	Mus musculus
Animal model
STAT protein	p-STAT3
Other

Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. PloS one Peter Y Yu, Heather L Gardner, Ryan Roberts, Hakan Cam, Seethalakshmi Hariharan, Ling Ren, Amy K LeBlanc, Hui Xiao, Jiayuh Lin, Denis C Guttridge, Xiaokui Mo, Chad E Bennett, Christopher C Coss, Yonghua Ling, Mitch A Phelps, Peter Houghton, Cheryl A London, 12, 7, None, 2017-07-27, 10.1371/journal.pone.0181885 DOI: 10.1371/journal.pone.0181885 PUBMED: 28750090 PMCID: PMC5531494